Publicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (18)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

2023

  1. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  2. Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques

    PLoS ONE, Vol. 18, Núm. 4 April

  3. Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia

    Science of the Total Environment, Vol. 894

  4. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

  5. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

    International Journal of COPD, Vol. 18, pp. 2473-2481

  6. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

  7. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

2022

  1. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

    Infection, Vol. 50, Núm. 1, pp. 179-189

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

2021

  1. The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 6, pp. 1075-1085

2020

  1. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

2019

  1. Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers

    Chest, Vol. 156, Núm. 6, pp. 1080-1091

2017

  1. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study

    Vaccine, Vol. 35, Núm. 39, pp. 5264-5270

2010

  1. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia

    Journal of Infection, Vol. 60, Núm. 2, pp. 106-113

2009

  1. Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia

    Thorax, Vol. 64, Núm. 6, pp. 496-501

  2. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia

    Chest, Vol. 135, Núm. 6, pp. 1572-1579

2003

  1. Community-acquired pneumonia in the elderly: Spanish multicentre study

    European Respiratory Journal, Vol. 21, Núm. 2, pp. 294-302